$CEHC: Some highlights!!! Will construct a DD all in one

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
$CEHC: Some highlights!!! Will construct a DD all in one for tomorrow!

Based on the two years of pilot programs, the company expects to receive approximately $3,000,000 in revenue over the next eight quarters in South Africa alone. The company is currently exploring opportunities in several other countries from which it would derive additional revenues. GLI anticipates billing clients in August

Now tell me this isn't bad ass and tells us that our future is insanely bright!

http://www.gli360.com/about/



ITEM 1.01. Entry into a Definitive Material Agreement

On May 9, 2013, Cephas Holdings, Inc. (the “Company”) entered into an Asset Purchase Agreement with Global Leadership Institute South Africa, LLC. (collectively, “Seller”) pursuant to which the Company shall acquire all business relationships, domain names, contracts if any, and trade secrets. The purchase price is three million (3,000,000) restricted common shares payable upon execution.



Leadership
David Altman, Managing Director, Global Leadership Institute with Bill Clinton, Founding Chairman, Clinton Global Intitiative
David Altman

Managing Director of The Global Leadership Institute (GLI)

The Global Leadership Institute is a for profit social entrepreneurial initiative, established under the laws of the state of Delaware.

Altman is also a Senior Advisor to BCIU, with a focus on government relations in sub-Saharan Africa; activities include establishing relationships with senior public and private sector leaders to develop trade and media outreach missions and joint programs focused on job creation through entrepreneurship. BCIU is non-profit organization established in 1955 at the initiative of the White House to promote international understanding. BCIU is funded by its corporate members which pay annual dues to the organization. Most of the members are household names: GE; Boeing; Citigroup; Coca-Cola; et. al.

Altman was the Executive Director of The US Export Council for 20 years, providing assistance to American firms seeking access to high growth markets in the Gulf States, Middle East and Africa. (1993 – 2010)

In 1993, with the support from U.S. Secretary of Commerce, Ron Brown, President Bill Clinton and Nelson Mandela, Altman developed the annual “Made In USA Expo” in Johannesburg. Bringing the first US companies to a Post Apartheid, South Africa.
These events, soon became the largest showcases of US Products and Services in Southern Africa.

According to the US Department of Commerce, the US Export Council’s efforts in the area of bi-lateral trade generated in excess of $3 billion in new exports from the United States to Southern Africa, in addition to numerous joint ventures, investments and technology transfers.

In South and East Africa, Altman was instrumental in opening the doors to the first formal trade and investment between Kenya,Uganda, Tanzania and South Africa.

Altman also played a role in facilitating South Africa’s first Post Apartheid US$750 million bond issue, which was managed by Goldman Sachs in London and the Swiss Bank Corporation.

In the United Arab Emirates, Altman developed an online trading platform with Tejari a division of Dubai World providing electronic access for small and medium sized US exporters to Middle East export markets.

Prior to joining the US Export Council, Mr. Altman was President of East West, a management and marketing company based in Los Angeles and Milan, Italy for 10 years.

Mr. Altman served on the Advisory Board of Disaster Psychiatry Outreach in New York and has worked in support of Amnesty International, UNICEF, The International Rescue Committee, El Rescate and the Red Cross

Mr. Altman also serves as President of his media firm, Jungle Media Ltd. which in addition to film finance has produced films for television, including Dead at Daybreak, released as “Orion” an award winning, foreign language detective series, based on the best selling novel by Deon Meyer.

As a publisher, Mr. Altman received a Golden Ink Award in New York for publishing excellence.



1. 1) THE PARTIES TO THIS AGREEMENT ARE:

THE SELLER:

Global Leadership Institute South Africa, LLC

2711 Centerville Road Suite 400

Wilmington, Delaware 19808

Share Structure: http://www.otcmarkets.com/edgar/GetFilingHtml...ID=9297067

As of the close of business on the record date, we had 300,000,000 shares of common stock authorized, of which 38,586,655 shares were outstanding, and 2,000,000 shares of preferred stock authorized, of which there were 2,000,000 shares outstanding. Each outstanding share of common stock is entitled to one vote per share and each outstanding share of Series B, Series C and Series D Preferred Stock is entitled to 10, 100 and 135 votes per share, respectively.


The approval of a majority of all outstanding votes is required for us to be able to approve and adopt an amendment to the Certificate of Incorporation. Under Delaware law and our organizational documents, we are entitled to obtain that approval by written consent. We have obtained written consents approving the amendment to the Certificate of Incorporation from stockholders holding approximately 82% of the voting power of our securities.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RingConn Joins BVB Women's Team: Tech Meets Sport

Updated Category News Views 64

Tech and Football: An Unlikely Alliance Alright, so here's a story that might perk your ears up—RingConn, a relative newcomer in the health tech world, has chosen to stake its future on a bet with Borussia Dortmund's women's football team. This isn't just your average brand-sponsorship slap-on-the-shirt deal; we're looking at a potential game-changer here, folks. Who...

Continue Reading
CVS Health to Split: New Paths for Growth

Updated Category News Views 64

The Evolution of CVS Health Walking through CVS Health's latest move feels like watching a torch split into two flames, each set to shine its own light in the healthcare industry. This behemoth of pharmacy and healthcare solutions is gearing up to divide into two independent, publicly traded entities by the first half of 2028. A decision not made lightly, this separation...

Continue Reading
Life with PAH: A Journey of Awareness and Hope

Updated Category News Views 224

Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...

Continue Reading
Stellar Snacks Shakes Up Pretzel Sector with Bold Launch

Updated Category News Views 48

Stellar Snacks' audacious venture into olive oil-based pretzels Ever thought pretzels would stir up a storm? Well, Stellar Snacks sure did. They're celebrating a blockbuster year by rolling out a brand-new line of olive oil-baked pretzel braids across Sprouts Farmers Market nationwide. This isn't just any rollout. It's a carefully crafted endeavor tailored to redefine how...

Continue Reading
Mazu Forum: Bridging Cultures and Marine Safety

Updated Category News Views 93

The 11th Global Mazu Culture Forum kicked off on November 1 in Putian City, Fujian Province—smack dab on the historical Meizhou Island. This ain’t just another talk-fest; it's a melting pot of ideas and achievements packaged with cultural flair and some serious tech muscle. Nestled in China's southeast, Meizhou Island serves as the heartland for Mazu culture, a beacon...

Continue Reading
Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 93

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Hugel's Sales Climb Despite Changes in Sales Models

Updated Category News Views 117

Hugel's Financial Fortunes in a Shifting Landscape Who would've thought? That’s the vibe hugging the numbers Hugel Inc. just dropped. Their performance for the first three quarters of 2026 is in the books, and results show consolidated net sales climbing 15% year-on-year. Just how did they pull this rabbit out of the hat? Let's dissect this a bit. Cracking the Code of...

Continue Reading
UP Fintech Faces Class Action: What's at Stake?

Updated Category News Views 32

Deep Dive into UP Fintech's Tumultuous Journey Let me tell you, nothing quite shakes the confidence like a stock dropping over 25% overnight. The folks invested in UP Fintech Holding Limited (NASDAQ: TIGR) are likely feeling that gut-wrenching sensation right about now. With a securities fraud class action tossed on the table against them, you can be sure the road ahead...

Continue Reading
Sebastian & Boiler Room's Bold Dive into Creative Synergy

Updated Category News Views 59

Call it a wild cosmic union or just a sharp, savvy partnership—either way, Sebastian Professional and Boiler Room have teamed up in a bold celebration of creativity that could shake things up. By leveraging their own unique legacies, they're producing "Centre Stage," a fresh content series spotlighting the explosive synergy where music and hair artistry meet. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Recent Insider Trading Insights on Teva Pharmaceutical Stock

Updated Category News Views 155

Recent Insider Trading at Teva Pharmaceutical Industries A notable insider transaction occurred recently, with Amir Weiss, the Chief Accounting Officer at Teva Pharmaceutical Industries Ltd (NYSE: TEVA), unloading shares worth $300,564 as reported by a recent SEC filing. Details of the Transaction According to the Form 4 filing submitted to the U.S. Securities and...

Continue Reading
TIER IV and Newmo Join Forces for Innovative Robotaxi Services

Updated Category News Views 266

Transforming Mobility with Robotaxi Services TIER IV, renowned for developing the first open-source software for autonomous driving, has teamed up with mobility startup Newmo to revolutionize transportation services. This partnership marks a significant step toward the commercialization of robotaxi services, offering solutions tailored for local communities. Your Solution...

Continue Reading
Investors of Wolfspeed Inc. Face Deadline for Class Action Claims

Updated Category News Views 262

Investors Urged to Take Action After Stock Price Drop Recent developments surrounding Wolfspeed, Inc. have raised significant concerns among investors, especially following the staggering drop in the company's stock price. Those who invested in Wolfspeed, often identified by its ticker WOLF, may now find themselves questioning their portfolio decisions. Amidst this...

Continue Reading
Team Falcons Triumphs at Esports World Cup 2025 Championship

Updated Category News Views 261

Team Falcons' Incredible Journey to Victory The culmination of the Esports World Cup 2025 showcased an exhilarating journey for Team Falcons, who emerged as the dominant force in this prestigious multi-title esports tournament. Over seven weeks, the tournament attracted a staggering 750 million viewers worldwide and recorded 350 million hours of online watch time. These...

Continue Reading
GENFIT's 2024 Registration Document and Annual Report Release

Updated Category News Views 224

GENFIT Files 2024 Universal Registration Document Lille, France - GENFIT (Nasdaq and Euronext: GNFT), a pioneering biopharmaceutical firm dedicated to the welfare of patients suffering from rare and life-threatening liver conditions, has achieved a significant milestone by filing its 2024 Universal Registration Document alongside its Annual Report on Form 20-F with...

Continue Reading